NCT01048736

Brief Summary

Aging is associated with declines in aerobic capacity, exercise tolerance, and functional endurance that lead to physical disability and loss of independence. Furthermore, the existing high prevalence of obesity in the elderly is greatly exacerbating these aging-related declines in function. To date, regular exercise is the only known therapy to consistently improve aerobic function, and perhaps delay the onset of disability. Although aerobic exercise training does benefit both aerobic capacity and endurance even in obese persons, some data show that the maximal efficacy of exercise for improving aerobic function is blunted by obesity. In addition, our preliminary data show a potential dose-response benefit of concomitant fat loss on exercise-induced improvements in aerobic function. Thus, combining an exercise intervention with caloric restriction resulting in fat loss may be more efficacious for improving aerobic function than exercise alone in obese elderly, a population at high risk for disability. The purpose of this study is to determine whether the amount of fat loss (achieved through controlled underfeeding) affects the magnitude of improvement in aerobic function (maximal aerobic capacity and endurance) in response to a standardized exercise training stimulus that follows current recommendations for older persons.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Oct 2009

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 11, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 14, 2010

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

January 20, 2026

Status Verified

July 1, 2018

Enrollment Period

4.9 years

First QC Date

January 11, 2010

Last Update Submit

January 15, 2026

Conditions

Keywords

obesityexerciseintensityweight lossdiet

Outcome Measures

Primary Outcomes (1)

  • maximal aerobic capacity (VO2max) and functional endurance (400 m walk time)

    assessment visits will take place at baseline and post 5 months intervention

Secondary Outcomes (1)

  • changes in specific CVD risk factors (inflammatory markers, blood lipids, blood pressure, and glucose tolerance)

    baseline and 5-month follow-up

Study Arms (3)

Exercise

ACTIVE COMPARATOR

All treatment groups will receive 4d/wk of exercise

Behavioral: Exercise Only

Exercise + Diet (-250 kcal/d deficit)

EXPERIMENTAL

Exercise 4d/wk with moderate caloric restriction (-250 kcal/d deficit) designed for low fat loss (EX+Low CR; \~4.5 kg weight loss),

Behavioral: Exercise + Diet

Exercise + Diet (-600 kcal/d deficit)

EXPERIMENTAL

Exercise 4d/wk with intensive caloric restriction (-600 kcal/d deficit) designed for high fat loss (EX+High CR; \~10.9 kg weight loss)

Behavioral: Exercise + Diet

Interventions

Exercise OnlyBEHAVIORAL

4 d/wk of aerobic exercise

Also known as: EX
Exercise
Exercise + DietBEHAVIORAL

Exercise 4d/wk with moderate caloric restriction (-250 kcal/d deficit) designed for low fat loss (EX+Low CR; \~4.5 kg weight loss).

Also known as: EX+Low CR
Exercise + Diet (-250 kcal/d deficit)

Eligibility Criteria

Age65 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • BMI=30-34.9 kg/m2
  • Sedentary for past 6 months (\<30 min, 3 d/wk of exercise, including walking)
  • Normal cognitive function (MMSE \>24)
  • No contraindications for participation in weight loss or exercise (e.g., severe arthritis or musculoskeletal disorders)
  • Able to provide own transportation to study visits and intervention
  • No drug abuse or excessive alcohol use (\> 7 drinks/week)
  • Not dependent on a cane or walker

You may not qualify if:

  • Weight loss or gain (±5%) in past 6 months
  • Body weight \>136.4 kg (DXA limit is 300 lbs)
  • Smoker (No nicotine within past year)
  • Osteoporosis (T-score ≥ -2.5)
  • Abnormal kidney function tests
  • Insulin-dependent or uncontrolled diabetes
  • Uncontrolled hypertension (BP\>200/110 mmHg)
  • Hypertriglyceridemia (TG\>400 mg/dl)
  • Past or current ischemic heart disease, angina, heart failure, peripheral artery disease, stroke, chronic respiratory disease, uncontrolled endocrine/metabolic disease, neurological or hematological disease, clinically evident edema
  • Cancer requiring treatment in past 2 years, except non-melanoma skin cancers
  • Severe anemia (Hb\<10 g/100 ml)
  • Hip fracture, hip or knee replacement, or spinal surgery in past 6 months
  • Regular use of medications that influence study variables (growth/steroid hormones, estrogen, anti-inflammatory, beta blockers, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest University

Winston-Salem, North Carolina, United States

Location

Related Publications (1)

  • Brinkley TE, Leng I, Bailey MJ, Houston DK, Hugenschmidt CE, Nicklas BJ, Hundley WG. Effects of Exercise and Weight Loss on Proximal Aortic Stiffness in Older Adults With Obesity. Circulation. 2021 Aug 31;144(9):684-693. doi: 10.1161/CIRCULATIONAHA.120.051943. Epub 2021 Aug 2.

MeSH Terms

Conditions

ObesitySedentary BehaviorMotor ActivityWeight Loss

Interventions

ExerciseDiet

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorBody Weight Changes

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2010

First Posted

January 14, 2010

Study Start

October 1, 2009

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

January 20, 2026

Record last verified: 2018-07

Locations